{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:55:33Z","timestamp":1793498133016,"version":"4.5.0"},"reference-count":87,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["jme.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:p>The genetics of pheochromocytoma and paraganglioma (PPGL) has become increasingly complex over the last two decades. The list of genes involved in the development of these tumors has grown steadily, and there are currently more than 20 driver genes implicated in either the hereditary or the sporadic nature of the disease. Although genetic diagnosis is achieved in about 75\u201380% of patients, genetic etiology remains unexplained in a significant percentage of cases. Patients lacking a genetic diagnosis include not only those with apparently sporadic PPGL but also patients with a family history of the disease or with multiple tumors, that meet the criteria to be considered as candidates for carrying germline mutations in yet undiscovered genes. Mutations in known PPGL genes deregulate three main signaling pathways (hypoxia, kinase signaling, and Wnt-signaling pathways), which could be the starting point for the development of personalized treatment for PPGL patients. Furthermore, the integration of results from several genomic high-throughput platforms enables the discovery of regulatory mechanisms that cannot be identified by analyzing each piece of information separately. These strategies are powerful tools for elucidating optimal therapeutic options based on molecular biomarkers in PPGL and represent an important step toward the achievement of precision medicine for patients with metastatic PPGL.<\/jats:p>","DOI":"10.1530\/jme-22-0167","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T13:27:46Z","timestamp":1671110866000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-6","source":"Crossref","is-referenced-by-count":61,"title":["Genetic bases of pheochromocytoma and paraganglioma"],"prefix":"10.1530","volume":"70","author":[{"given":"Alberto","family":"Casc\u00f3n","sequence":"first","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-9415","authenticated-orcid":true,"given":"Bruna","family":"Calsina","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Monteagudo","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-3039","authenticated-orcid":true,"given":"Sara","family":"Mellid","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"D\u00edaz-Talavera","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Curr\u00e1s-Freixes","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-5902","authenticated-orcid":true,"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Molecular Cancer Research","first-page":"1476","article-title":"Mastermind like transcriptional coactivator 3 (MAML3) drives neuroendocrine tumor progression","volume":"19","author":"Alzofon","year":"2021","unstructured":"Alzofon NKoc KPanwell KPozdeyev NMarshall CBAlbuja-Cruz MRaeburn CDNathanson KLCohen DLWierman ME2021Mastermind like transcriptional coactivator 3 (MAML3) drives neuroendocrine tumor progression. Molecular Cancer Research191476\u20131485. (https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0992)"},{"key":"bib2","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"3822","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","unstructured":"Amar LBaudin EBurnichon NPeyrard SSilvera SBertherat JBertagna XSchlumberger MJeunemaitre XGimenez-Roqueplo AP2007Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. Journal of Clinical Endocrinology and Metabolism923822\u20133828. (https:\/\/doi.org\/10.1210\/jc.2007-0709)"},{"key":"bib3","series-title":"Nature Reviews Endocrinology","first-page":"435","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","unstructured":"Amar LPacak KSteichen OAkker SAAylwin SJBBaudin EBuffet ABurnichon NClifton-Bligh RJDahia PLM2021International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nature Reviews Endocrinology17435\u2013444. (https:\/\/doi.org\/10.1038\/s41574-021-00492-3)"},{"key":"bib4","series-title":"Journal of Medical Genetics","first-page":"384","article-title":"Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD","volume":"55","author":"Andrews","year":"2018","unstructured":"Andrews KAAscher DBPires DEVBarnes DRVialard LCasey RTBradshaw NAdlard JAylwin SBrennan P2018Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD. Journal of Medical Genetics55384\u2013394. (https:\/\/doi.org\/10.1136\/jmedgenet-2017-105127)"},{"key":"bib5","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"e350","article-title":"Genotype-phenotype features of germline variants of the TMEM127 pheochromocytoma susceptibility gene: a 10-year update","volume":"106","author":"Armaiz-Pena","year":"2021","unstructured":"Armaiz-Pena GFlores SKCheng ZMZhang XEsquivel EPoullard NVaidyanathan ALiu QMichalek JSantillan-Gomez AA2021Genotype-phenotype features of germline variants of the TMEM127 pheochromocytoma susceptibility gene: a 10-year update. Journal of Clinical Endocrinology and Metabolism106e350\u2013e364. (https:\/\/doi.org\/10.1210\/clinem\/dgaa741)"},{"key":"bib6","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"717","article-title":"Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators","volume":"96","author":"Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez MFeng LJohnson MMEjaz SHabra MARich TBusaidy NCote GJPerrier NPhan A2011Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. Journal of Clinical Endocrinology and Metabolism96717\u2013725. (https:\/\/doi.org\/10.1210\/jc.2010-1946)"},{"key":"bib7","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1492","article-title":"Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma","volume":"98","author":"Ayala-Ramirez","year":"2013","unstructured":"Ayala-Ramirez MPalmer JLHofmann MCde la Cruz MMoon BSWaguespack SGHabra MAJimenez C2013Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma. Journal of Clinical Endocrinology and Metabolism981492\u20131497. (https:\/\/doi.org\/10.1210\/jc.2012-4231)"},{"key":"bib8","series-title":"Nature Genetics","first-page":"349","article-title":"Systematic analysis of telomere length and somatic alterations in 31 cancer types","volume":"49","author":"Barthel","year":"2017","unstructured":"Barthel FPWei WTang MMartinez-Ledesma EHu XAmin SBAkdemir KCSeth SSong XWang Q2017Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nature Genetics49349\u2013357. (https:\/\/doi.org\/10.1038\/ng.3781)"},{"key":"bib9","series-title":"European Journal of Endocrinology","first-page":"R111","article-title":"Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma","volume":"171","author":"Baudin","year":"2014","unstructured":"Baudin EHabra MADeschamps FCote GDumont FCabanillas MArfi-Roufe JBerdelou AMoon BAl Ghuzlan A2014Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma. European Journal of Endocrinology171R111\u2013R122. (https:\/\/doi.org\/10.1530\/EJE-14-0113)"},{"key":"bib10","series-title":"Lancet. Oncology","first-page":"366","article-title":"SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma","volume":"11","author":"Bayley","year":"2010","unstructured":"Bayley JPKunst HPCascon ASampietro MLGaal JKorpershoek EHinojar-Gutierrez ATimmers HJHoefsloot LHHermsen MA2010SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet. Oncology11366\u2013372. (https:\/\/doi.org\/10.1016\/S1470-2045(1070007-3)"},{"key":"bib11","series-title":"Journal of Medical Genetics","first-page":"513","article-title":"Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma","volume":"56","author":"Ben Aim","year":"2019","unstructured":"Ben Aim LPigny PCastro-Vega LJBuffet AAmar LBertherat JDrui DGuilhem IBaudin ELussey-Lepoutre C2019Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma. Journal of Medical Genetics56513\u2013520. (https:\/\/doi.org\/10.1136\/jmedgenet-2018-105714)"},{"key":"bib12","series-title":"Clinical Endocrinology","first-page":"338","article-title":"Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review","volume":"82","author":"Brito","year":"2015","unstructured":"Brito JPAsi NBancos IGionfriddo MRZeballos-Palacios CLLeppin ALUndavalli CWang ZDomecq JPPrustsky G2015Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review. Clinical Endocrinology82338\u2013345. (https:\/\/doi.org\/10.1111\/cen.12530)"},{"key":"bib13","series-title":"Cancer Research","first-page":"1914","article-title":"Germline mutations in the mitochondrial 2-oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas","volume":"78","author":"Buffet","year":"2018","unstructured":"Buffet AMorin ACastro-Vega LJHabarou FLussey-Lepoutre CLetouze ELefebvre HGuilhem IHaissaguerre MRaingeard I2018Germline mutations in the mitochondrial 2-oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas. Cancer Research781914\u20131922. (https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2463)"},{"key":"bib14","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"459","article-title":"Germline DLST variants promote epigenetic modifications in pheochromocytoma-paraganglioma","volume":"106","author":"Buffet","year":"2021","unstructured":"Buffet AZhang JRebel HCorssmit EPMJansen JCHensen EFBovee JVMGMorini AGimenez-Roqueplo APHes FJ2021Germline DLST variants promote epigenetic modifications in pheochromocytoma-paraganglioma. Journal of Clinical Endocrinology and Metabolism106459\u2013471. (https:\/\/doi.org\/10.1210\/clinem\/dgaa819)"},{"key":"bib15","series-title":"Human Molecular Genetics","first-page":"5397","article-title":"Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma","volume":"21","author":"Burnichon","year":"2012a","unstructured":"Burnichon NBuffet AParfait BLetouze ELaurendeau ILoriot CPasmant EAbermil NValeyrie-Allanore LBertherat J2012aSomatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. Human Molecular Genetics215397\u20135405. (https:\/\/doi.org\/10.1093\/hmg\/dds374)"},{"key":"bib16","series-title":"Clinical Cancer Research","first-page":"2828","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012b","unstructured":"Burnichon NCascon ASchiavi FMorales NPComino-Mendez IAbermil NInglada-Perez Lde Cubas AAAmar LBarontini M2012bMAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clinical Cancer Research182828\u20132837. (https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0160)"},{"key":"bib17","series-title":"Journal of Medical Genetics","first-page":"125","article-title":"Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma","volume":"54","author":"Burnichon","year":"2017","unstructured":"Burnichon NMazzella JMDrui DAmar LBertherat JCoupier IDelemer BGuilhem IHerman PKerlan V2017Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma. Journal of Medical Genetics54125\u2013133. (https:\/\/doi.org\/10.1136\/jmedgenet-2016-104297)"},{"key":"bib18","series-title":"Theranostics","first-page":"4946","article-title":"Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p\/TSC2\/mTOR axis in metastatic pheochromocytoma\/paraganglioma","volume":"9","author":"Calsina","year":"2019","unstructured":"Calsina BCastro-Vega LJTorres-Perez RInglada-Perez LCurras-Freixes MRoldan-Romero JMMancikova VLeton RRemacha LSantos M2019Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p\/TSC2\/mTOR axis in metastatic pheochromocytoma\/paraganglioma. Theranostics94946\u20134958. (https:\/\/doi.org\/10.7150\/thno.35458)"},{"key":"bib19","series-title":"Genetics in Medicine","first-page":"1652","article-title":"Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients","volume":"20","author":"Calsina","year":"2018","unstructured":"Calsina BCurras-Freixes MBuffet APons TContreras LLeton RComino-Mendez IRemacha LCalatayud MObispo B2018Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients. Genetics in Medicine201652\u20131662. (https:\/\/doi.org\/10.1038\/s41436-018-0068-7)"},{"key":"bib20","series-title":"Journal of the National Cancer Institute","first-page":"djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Cascon","year":"2015","unstructured":"Cascon AComino-Mendez ICurras-Freixes Mde Cubas AAContreras LRichter SPeitzsch MMancikova VInglada-Perez LPerez-Barrios A2015Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene. Journal of the National Cancer Institute107djv053. (https:\/\/doi.org\/10.1093\/jnci\/djv053)"},{"key":"bib21","series-title":"Cancers (Basel)","first-page":"683","article-title":"Pheochromocytomas and paragangliomas: bypassing cellular respiration","volume":"11","author":"Cascon","year":"2019","unstructured":"Cascon ARemacha LCalsina BRobledo M2019Pheochromocytomas and paragangliomas: bypassing cellular respiration. Cancers (Basel)11683. (https:\/\/doi.org\/10.3390\/cancers11050683)"},{"key":"bib22","series-title":"Molecular Genetics and Genomic Medicine","first-page":"237","article-title":"SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity","volume":"5","author":"Casey","year":"2017a","unstructured":"Casey RTAscher DBRattenberry EIzatt LAndrews KASimpson HLChallis BPark SMBulusu VRLalloo F2017aSDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity. Molecular Genetics and Genomic Medicine5237\u2013250. (https:\/\/doi.org\/10.1002\/mgg3.279)"},{"key":"bib23","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"4013","article-title":"Clinical and molecular features of renal and pheochromocytoma\/paraganglioma tumor association syndrome (RAPTAS): case series and literature review","volume":"102","author":"Casey","year":"2017b","unstructured":"Casey RTWarren AYMartin JEChallis BGRattenberry EWhitworth JAndrews KARoberts TClark GRWest H2017bClinical and molecular features of renal and pheochromocytoma\/paraganglioma tumor association syndrome (RAPTAS): case series and literature review. Journal of Clinical Endocrinology and Metabolism1024013\u20134022. (https:\/\/doi.org\/10.1210\/jc.2017-00562)"},{"key":"bib24","series-title":"Human Molecular Genetics","first-page":"2440","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","unstructured":"Castro-Vega LJBuffet ADe Cubas AACascon AMenara MKhalifa EAmar LAzriel SBourdeau IChabre O2014Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Human Molecular Genetics232440\u20132446. (https:\/\/doi.org\/10.1093\/hmg\/ddt639)"},{"key":"bib25","series-title":"Oncogene","first-page":"1080","article-title":"Rethinking pheochromocytomas and paragangliomas from a genomic perspective","volume":"35","author":"Castro-Vega","year":"2016","unstructured":"Castro-Vega LJLepoutre-Lussey CGimenez-Roqueplo APFavier J2016Rethinking pheochromocytomas and paragangliomas from a genomic perspective. Oncogene351080\u20131089. (https:\/\/doi.org\/10.1038\/onc.2015.172)"},{"key":"bib26","series-title":"Nature Genetics","first-page":"663","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-Mendez","year":"2011","unstructured":"Comino-Mendez IGracia-Aznarez FJSchiavi FLanda ILeandro-Garcia LJLeton RHonrado ERamos-Medina RCaronia DPita G2011Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nature Genetics43663\u2013667. (https:\/\/doi.org\/10.1038\/ng.861)"},{"key":"bib27","series-title":"Journal of Molecular Medicine","first-page":"1247","article-title":"Functional and in silico assessment of MAX variants of unknown significance","volume":"93","author":"Comino-Mendez","year":"2015","unstructured":"Comino-Mendez ILeandro-Garcia LJMontoya GInglada-Perez Lde Cubas AACurras-Freixes MTysoe CIzatt LLeton RGomez-Grana \u00c12015Functional and in silico assessment of MAX variants of unknown significance. Journal of Molecular Medicine931247\u20131255. (https:\/\/doi.org\/10.1007\/s00109-015-1306-y)"},{"key":"bib28","series-title":"Journal of Molecular Diagnostics","first-page":"575","article-title":"PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics","volume":"19","author":"Curras-Freixes","year":"2017","unstructured":"Curras-Freixes MPineiro-Yanez EMontero-Conde CApellaniz-Ruiz MCalsina BMancikova VRemacha LRichter SErcolino TRogowski-Lehmann N2017PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics. Journal of Molecular Diagnostics19575\u2013588. (https:\/\/doi.org\/10.1016\/j.jmoldx.2017.04.009)"},{"key":"bib29","series-title":"Cancer Cell","first-page":"159","article-title":"Pheochromocytomas and paragangliomas, genetically diverse and minimalist, all at once!","volume":"31","author":"Dahia","year":"2017","unstructured":"Dahia PL2017Pheochromocytomas and paragangliomas, genetically diverse and minimalist, all at once!Cancer Cell31159\u2013161. (https:\/\/doi.org\/10.1016\/j.ccell.2017.01.009)"},{"key":"bib30","series-title":"Endocrine-Related Cancer","first-page":"T41","article-title":"Hereditary endocrine tumours: current state-of-the-art and research opportunities: metastatic pheochromocytomas and paragangliomas: Proceedings of the MEN2019 workshop","volume":"27","author":"Dahia","year":"2020","unstructured":"Dahia PLMClifton-Bligh RGimenez-Roqueplo APRobledo MJimenez C2020Hereditary endocrine tumours: current state-of-the-art and research opportunities: metastatic pheochromocytomas and paragangliomas: Proceedings of the MEN2019 workshop. Endocrine-Related Cancer27T41\u2013T52. (https:\/\/doi.org\/10.1530\/ERC-19-0435)"},{"key":"bib31","series-title":"Current Opinion in Oncology","first-page":"23","article-title":"An update on adult forms of hereditary pheochromocytomas and paragangliomas","volume":"33","author":"Dariane","year":"2021","unstructured":"Dariane CGoncalves JTimsit MOFavier J2021An update on adult forms of hereditary pheochromocytomas and paragangliomas. Current Opinion in Oncology3323\u201332. (https:\/\/doi.org\/10.1097\/CCO.0000000000000694)"},{"key":"bib32","series-title":"Journal of Endocrinological Investigation","first-page":"15","article-title":"Management and outcome of metastatic pheochromocytomas\/paragangliomas: an overview","volume":"44","author":"De Filpo","year":"2021","unstructured":"De Filpo GMaggi MMannelli MCanu L2021Management and outcome of metastatic pheochromocytomas\/paragangliomas: an overview. Journal of Endocrinological Investigation4415\u201325. (https:\/\/doi.org\/10.1007\/s40618-020-01344-z)"},{"key":"bib33","series-title":"Endocrine-Related Cancer","first-page":"L79","article-title":"Molecular and phenotypic evaluation of a novel germline TMEM127 mutation with an uncommon clinical presentation","volume":"24","author":"Deng","year":"2017","unstructured":"Deng YFlores SKCheng ZQin YSchwartz RCMalchoff CDahia PLM2017Molecular and phenotypic evaluation of a novel germline TMEM127 mutation with an uncommon clinical presentation. Endocrine-Related Cancer24L79\u2013L82. (https:\/\/doi.org\/10.1530\/ERC-17-0359)"},{"key":"bib34","series-title":"Endocrine-Related Cancer","first-page":"1","article-title":"Tert structural rearrangements in metastatic pheochromocytomas","volume":"25","author":"Dwight","year":"2018","unstructured":"Dwight TFlynn AAmarasinghe KBenn DELupat RLi JCameron DLHogg ABalachander SCandiloro ILM2018Tert structural rearrangements in metastatic pheochromocytomas. Endocrine-Related Cancer251\u20139. (https:\/\/doi.org\/10.1530\/ERC-17-0306)"},{"key":"bib35","series-title":"Endocrine-Related Cancer","first-page":"897","article-title":"Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome","volume":"11","author":"Eisenhofer","year":"2004","unstructured":"Eisenhofer GHuynh TTPacak KBrouwers FMWalther MMLinehan WMMunson PJMannelli MGoldstein DSElkahloun AG2004Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocrine-Related Cancer11897\u2013911. (https:\/\/doi.org\/10.1677\/erc.1.00838)"},{"key":"bib36","series-title":"American Journal of Medical Genetics. Part A","first-page":"327","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","unstructured":"Evans DGHoward EGiblin CClancy TSpencer HHuson SMLalloo F2010Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. American Journal of Medical Genetics. Part A152A327\u2013332. (https:\/\/doi.org\/10.1002\/ajmg.a.33139)"},{"key":"bib37","series-title":"Nature Reviews. Endocrinology","first-page":"101","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","unstructured":"Favier JAmar LGimenez-Roqueplo AP2015Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nature Reviews. Endocrinology11101\u2013111. (https:\/\/doi.org\/10.1038\/nrendo.2014.188)"},{"key":"bib38","series-title":"Nature Communications","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","unstructured":"Fishbein LKhare SWubbenhorst BDeSloover DD'Andrea KMerrill SCho NWGreenberg RAElse TMontone K2015Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nature Communications6 6140. (https:\/\/doi.org\/10.1038\/ncomms7140)"},{"key":"bib39","series-title":"Cancer Cell","first-page":"181","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","unstructured":"Fishbein LLeshchiner IWalter VDanilova LRobertson AGJohnson ARLichtenberg TMMurray BAGhayee HKElse T2017Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell31181\u2013193. (https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001)"},{"key":"bib40","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"e3142","article-title":"Functional characterization of TMEM127 variants reveals novel insights into its membrane topology and trafficking","volume":"105","author":"Flores","year":"2020","unstructured":"Flores SKDeng YCheng ZZhang XTao SSaliba AChu IBurnichon NGimenez-Roqueplo APWang E2020Functional characterization of TMEM127 variants reveals novel insights into its membrane topology and trafficking. Journal of Clinical Endocrinology and Metabolism105e3142\u2013e3156. (https:\/\/doi.org\/10.1210\/clinem\/dgaa396)"},{"key":"bib41","series-title":"Cancer Research","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","unstructured":"Gimenez-Roqueplo APFavier JRustin PRieubland CCrespin MNau VKhau Van Kien PCorvol PPlouin PFJeunemaitre X2003Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Research635615\u20135621."},{"key":"bib42","series-title":"Frontiers of Hormone Research","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000074657","article-title":"The genetic basis of pheochromocytoma","volume":"31","author":"Gimm","year":"2004","unstructured":"Gimm OKoch CAJanuszewicz AOpocher GNeumann HP2004The genetic basis of pheochromocytoma. Frontiers of Hormone Research3145\u201360. (https:\/\/doi.org\/10.1159\/000074657)"},{"key":"bib44","series-title":"Journal of Medical Genetics","article-title":"UK recommendations for SDHA germline genetic testing and surveillance in clinical practice","author":"Hanson","year":"2022","unstructured":"Hanson HDurkie MLalloo FIzatt LMcVeigh TPCook JABrewer CDrummond JButler SCranston T2022UK recommendations for SDHA germline genetic testing and surveillance in clinical practice. Journal of Medical Genetics [epub]. (https:\/\/doi.org\/10.1136\/jmedgenet-2021-108355)"},{"key":"bib45","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"2367","article-title":"Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono study): a European network for the study of adrenal tumors retrospective study","volume":"104","author":"Hescot","year":"2019","unstructured":"Hescot SCurras-Freixes MDeutschbein Tvan Berkel AVezzosi DAmar Lde la Fouchardiere CValdes NRiccardi FDo Cao C2019Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono study): a European network for the study of adrenal tumors retrospective study. Journal of Clinical Endocrinology and Metabolism1042367\u20132374. (https:\/\/doi.org\/10.1210\/jc.2018-01968)"},{"key":"bib46","series-title":"Current Treatment Options in Oncology","article-title":"Emerging treatments for advanced\/metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Ilanchezhian","year":"2020","unstructured":"Ilanchezhian MJha APacak KDel Rivero J2020Emerging treatments for advanced\/metastatic pheochromocytoma and paraganglioma. Current Treatment Options in Oncology21 85. (https:\/\/doi.org\/10.1007\/s11864-020-00787-z)"},{"key":"bib47","series-title":"Current Oncology Reports","article-title":"Treatment for malignant pheochromocytomas and paragangliomas: 5 years of progress","volume":"19","author":"Jimenez","year":"2017","unstructured":"Jimenez PTatsui CJessop AThosani SJimenez C2017Treatment for malignant pheochromocytomas and paragangliomas: 5 years of progress. Current Oncology Reports19 83. (https:\/\/doi.org\/10.1007\/s11912-017-0643-0)"},{"key":"bib48","series-title":"Clinical Cancer Research","first-page":"760","article-title":"Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma","volume":"25","author":"Job","year":"2019","unstructured":"Job SDraskovic IBurnichon NBuffet ACros JLepine CVenisse ARobidel EVerkarre VMeatchi T2019Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma. Clinical Cancer Research25760\u2013770. (https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0139)"},{"key":"bib49","series-title":"Advances in Anatomic Pathology","first-page":"47","article-title":"Advances in adrenal and extra-adrenal paraganglioma: practical synopsis for pathologists","volume":"30","author":"Juhlin","year":"2022","unstructured":"Juhlin CCMete O 2022Advances in adrenal and extra-adrenal paraganglioma: practical synopsis for pathologists. Advances in Anatomic Pathology3047\u201357. (https:\/\/doi.org\/10.1097\/PAP.0000000000000365)"},{"key":"bib50","series-title":"Endocrine-Related Cancer","first-page":"387","article-title":"Structural and functional consequences of succinate dehydrogenase subunit B mutations","volume":"22","author":"Kim","year":"2015","unstructured":"Kim ERath EMTsang VHDuff APRobinson BGChurch WBBenn DEDwight TClifton-Bligh RJ2015Structural and functional consequences of succinate dehydrogenase subunit B mutations. Endocrine-Related Cancer22387\u2013397. (https:\/\/doi.org\/10.1530\/ERC-15-0099)"},{"key":"bib51","series-title":"Endocrine-Related Cancer","first-page":"405","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","unstructured":"Kimura NTakayanagi RTakizawa NItagaki EKatabami TKakoi NRakugi HIkeda YTanabe ANigawara T2014Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocrine-Related Cancer21405\u2013414. (https:\/\/doi.org\/10.1530\/ERC-13-0494)"},{"key":"bib52","series-title":"American Journal of Human Genetics","first-page":"514","article-title":"Mutation and cancer: neuroblastoma and pheochromocytoma","volume":"24","author":"Knudson","year":"1972","unstructured":"Knudson AGJrStrong LC1972Mutation and cancer: neuroblastoma and pheochromocytoma. American Journal of Human Genetics24514\u2013532."},{"key":"bib53","series-title":"Cancers (Basel)","first-page":"1070","article-title":"Pheochromocytomas and paragangliomas: new developments with regard to classification, genetics, and cell of origin","volume":"11","author":"Koopman","year":"2019","unstructured":"Koopman KGaal Jde Krijger RR2019Pheochromocytomas and paragangliomas: new developments with regard to classification, genetics, and cell of origin. Cancers (Basel)111070. (https:\/\/doi.org\/10.3390\/cancers11081070)"},{"key":"bib54","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"E1472","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","unstructured":"Korpershoek EFavier JGaal JBurnichon Nvan Gessel BOudijk LBadoual CGadessaud NVenisse ABayley JP2011SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. Journal of Clinical Endocrinology and Metabolism96E1472\u2013E1476. (https:\/\/doi.org\/10.1210\/jc.2011-1043)"},{"key":"bib55","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"453","article-title":"Complex MAX rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis","volume":"101","author":"Korpershoek","year":"2016","unstructured":"Korpershoek EKoffy DEussen BHOudijk LPapathomas TGvan Nederveen FHBelt EJFranssen GJRestuccia DFKrol NM2016Complex MAX rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis. Journal of Clinical Endocrinology and Metabolism101453\u2013460. (https:\/\/doi.org\/10.1210\/jc.2015-2592)"},{"key":"bib56","series-title":"Endocrine Pathology","first-page":"213","article-title":"Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours","volume":"28","author":"Lam","year":"2017","unstructured":"Lam AK2017Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocrine Pathology28213\u2013227. (https:\/\/doi.org\/10.1007\/s12022-017-9484-5)"},{"key":"bib57","series-title":"Journal of Hypertension","first-page":"1443","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","unstructured":"Lenders JWMKerstens MNAmar LPrejbisz ARobledo MTaieb DPacak KCrona JZelinka TMannelli M2020Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. Journal of Hypertension381443\u20131456. (https:\/\/doi.org\/10.1097\/HJH.0000000000002438)"},{"key":"bib58","series-title":"Cancer Cell","first-page":"739","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouze","year":"2013","unstructured":"Letouze EMartinelli CLoriot CBurnichon NAbermil NOttolenghi CJanin MMenara MNguyen ATBenit P2013SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell23739\u2013752. (https:\/\/doi.org\/10.1016\/j.ccr.2013.04.018)"},{"key":"bib59","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"E954","article-title":"Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations","volume":"97","author":"Loriot","year":"2012","unstructured":"Loriot CBurnichon NGadessaud NVescovo LAmar LLibe RBertherat JPlouin PFJeunemaitre XGimenez-Roqueplo AP2012Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations. Journal of Clinical Endocrinology and Metabolism97E954\u2013E962. (https:\/\/doi.org\/10.1210\/jc.2011-3437)"},{"key":"bib60","series-title":"Frontiers in Endocrinology (Lausanne)","article-title":"Familial acromegaly and bilateral asynchronous pheochromocytomas in a female patient with a MAX mutation: a case report","volume":"12","author":"Mamedova","year":"2021","unstructured":"Mamedova EVasilyev EPetrov VBuryakina STiulpakov ABelaya Z2021Familial acromegaly and bilateral asynchronous pheochromocytomas in a female patient with a MAX mutation: a case report. Frontiers in Endocrinology (Lausanne)12 683492. (https:\/\/doi.org\/10.3389\/fendo.2021.683492)"},{"key":"bib61","series-title":"Endocrine Pathology","first-page":"90","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","unstructured":"Mete OAsa SLGill AJKimura Nde Krijger RRTischler A2022Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocrine Pathology3390\u2013114. (https:\/\/doi.org\/10.1007\/s12022-022-09704-6)"},{"key":"bib62","series-title":"American Journal of Surgical Pathology","first-page":"1264","article-title":"Significance of alpha-inhibin expression in pheochromocytomas and paragangliomas","volume":"45","author":"Mete","year":"2021","unstructured":"Mete OPakbaz SLerario AMGiordano TJAsa SL2021Significance of alpha-inhibin expression in pheochromocytomas and paragangliomas. American Journal of Surgical Pathology451264\u20131273. (https:\/\/doi.org\/10.1097\/PAS.0000000000001715)"},{"key":"bib63","series-title":"Endocrine-Related Cancer","first-page":"1035","article-title":"Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation","volume":"15","author":"Milos","year":"2008","unstructured":"Milos INFrank-Raue KWohllk NMaia ALPusiol EPatocs ARobledo MBiarnes JBarontini MLinks TP2008Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Endocrine-Related Cancer151035\u20131041. (https:\/\/doi.org\/10.1677\/ERC-08-0105)"},{"key":"bib64","series-title":"Cancers (Basel)","first-page":"4785","article-title":"Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma\/paraganglioma","volume":"13","author":"Monteagudo","year":"2021","unstructured":"Monteagudo MMartinez PLeandro-Garcia LJMartinez-Montes \u00c1MCalsina BPulgarin-Alfaro MDiaz-Talavera AMellid SLeton RGil E2021Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma\/paraganglioma. Cancers (Basel)134785. (https:\/\/doi.org\/10.3390\/cancers13194758)"},{"key":"bib65","series-title":"Cell Reports","first-page":"4551","article-title":"TET-mediated hypermethylation primes SDH-deficient cells for HIF2alpha-driven mesenchymal transition","volume":"30","author":"Morin","year":"2020","unstructured":"Morin AGoncalves JMoog SCastro-Vega LJJob SBuffet AFontenille MJWoszczyk JGimenez-Roqueplo APLetouze E2020TET-mediated hypermethylation primes SDH-deficient cells for HIF2alpha-driven mesenchymal transition. Cell Reports304551\u20134566.e7. (https:\/\/doi.org\/10.1016\/j.celrep.2020.03.022)"},{"key":"bib43","series-title":"Nature Reviews Endocrinology","first-page":"233","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","unstructured":"NGS in PPGL (NGSnPPGL) Study Group, Toledo RABurnichon NCascon ABenn DEBayley JPWelander JTops CMFirth HDwight T2017Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nature Reviews Endocrinology13233\u2013247. (https:\/\/doi.org\/10.1038\/nrendo.2016.185)"},{"key":"bib66","series-title":"European Journal of Cancer","first-page":"32","article-title":"Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma","volume":"169","author":"Pamporaki","year":"2022","unstructured":"Pamporaki CProdanov TMeuter LBerends AMABechmann NConstantinescu GBeuschlein FRemde HJanuszewicz AKerstens MN2022Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma. European Journal of Cancer16932\u201341. (https:\/\/doi.org\/10.1016\/j.ejca.2022.03.032)"},{"key":"bib67","series-title":"Cancers (Basel)","first-page":"436","article-title":"Pheochromocytomas and paragangliomas: from genetic diversity to targeted therapies","volume":"11","author":"Pang","year":"2019","unstructured":"Pang YLiu YPacak KYang C2019Pheochromocytomas and paragangliomas: from genetic diversity to targeted therapies. Cancers (Basel)11436. (https:\/\/doi.org\/10.3390\/cancers11040436)"},{"key":"bib68","series-title":"Modern Pathology","first-page":"807","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","unstructured":"Papathomas TGOudijk LPersu AGill AJvan Nederveen FTischler ASTissier FVolante MMatias-Guiu XSmid M2015SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Modern Pathology28807\u2013821. (https:\/\/doi.org\/10.1038\/modpathol.2015.41)"},{"key":"bib69","series-title":"Annals of Surgical Oncology","first-page":"1329","article-title":"Update on pheochromocytoma and paraganglioma from the SSO endocrine\/head and neck disease-site work group. Part 1 of 2: Advances in pathogenesis and diagnosis of pheochromocytoma and paraganglioma","volume":"27","author":"Patel","year":"2020","unstructured":"Patel DPhay JEYen TWFDickson PVWang TSGarcia RYang ADSolorzano CCKim LT2020Update on pheochromocytoma and paraganglioma from the SSO endocrine\/head and neck disease-site work group. Part 1 of 2: Advances in pathogenesis and diagnosis of pheochromocytoma and paraganglioma. Annals of Surgical Oncology271329\u20131337. (https:\/\/doi.org\/10.1245\/s10434-020-08220-3)"},{"key":"bib70","series-title":"Hormone and Metabolic Research","first-page":"784","article-title":"Pancreatic neuroendocrine neoplasm associated with a familial MAX deletion","volume":"52","author":"Petignot","year":"2020","unstructured":"Petignot SDaly AFCastermans EKorpershoek EScagnol IBeckers PDideberg VRohmer VBours VBeckers A2020Pancreatic neuroendocrine neoplasm associated with a familial MAX deletion. Hormone and Metabolic Research52784\u2013787. (https:\/\/doi.org\/10.1055\/a-1186-0790)"},{"key":"bib71","series-title":"Frontiers in Endocrinology (Lausanne)","article-title":"Carney triad, Carney-Stratakis syndrome, 3PAS and other tumors due to SDH deficiency","volume":"12","author":"Pitsava","year":"2021","unstructured":"Pitsava GSettas NFaucz FRStratakis CA2021Carney triad, Carney-Stratakis syndrome, 3PAS and other tumors due to SDH deficiency. Frontiers in Endocrinology (Lausanne)12 680609. (https:\/\/doi.org\/10.3389\/fendo.2021.680609)"},{"key":"bib72","series-title":"Human Molecular Genetics","first-page":"2231","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","unstructured":"Pollard PJBriere JJAlam NABarwell JBarclay EWortham NCHunt TMitchell MOlpin SMoat SJ2005Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Human Molecular Genetics142231\u20132239. (https:\/\/doi.org\/10.1093\/hmg\/ddi227)"},{"key":"bib73","series-title":"Nature Genetics","first-page":"229","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma","volume":"42","author":"Qin","year":"2010","unstructured":"Qin YYao LKing EEBuddavarapu KLenci REChocron ESLechleiter JDSass MAronin NSchiavi F2010Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nature Genetics42229\u2013233. (https:\/\/doi.org\/10.1038\/ng.533)"},{"key":"bib74","series-title":"Clinical Cancer Research","first-page":"6315","article-title":"Targeted exome sequencing of Krebs cycle genes reveals candidate cancer\u2013predisposing mutations in pheochromocytomas and paragangliomas","volume":"23","author":"Remacha","year":"2017","unstructured":"Remacha LComino-Mendez IRichter SContreras LCurras-Freixes MPita GLeton RGalarreta ATorres-Perez RHonrado E2017Targeted exome sequencing of Krebs cycle genes reveals candidate cancer\u2013predisposing mutations in pheochromocytomas and paragangliomas. Clinical Cancer Research236315\u20136324. (https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2250)"},{"key":"bib75","series-title":"American Journal of Human Genetics","first-page":"651","article-title":"Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas","volume":"104","author":"Remacha","year":"2019","unstructured":"Remacha LPirman DMahoney CEColoma JCalsina BCurras-Freixes MLeton RTorres-Perez RRichter SPita G2019Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas. American Journal of Human Genetics104651\u2013664. (https:\/\/doi.org\/10.1016\/j.ajhg.2019.02.017)"},{"key":"bib76","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"359","article-title":"Epigenetic mutation of the succinate dehydrogenase C promoter in a patient with two paragangliomas","volume":"101","author":"Richter","year":"2016","unstructured":"Richter SKlink BNacke BdeCubas AAMangelis ARapizzi EMeinhardt MSkondra CMannelli MRobledo M 2016Epigenetic mutation of the succinate dehydrogenase C promoter in a patient with two paragangliomas. Journal of Clinical Endocrinology and Metabolism101359\u2013363. (https:\/\/doi.org\/10.1210\/jc.2015-3856)"},{"key":"bib77","series-title":"International Journal of Molecular Sciences","first-page":"1450","article-title":"Genetics of pheochromocytomas and paragangliomas determine the therapeutical approach","volume":"23","author":"Sarkadi","year":"2022","unstructured":"Sarkadi BSaskoi EButz HPatocs A2022Genetics of pheochromocytomas and paragangliomas determine the therapeutical approach. International Journal of Molecular Sciences231450. (https:\/\/doi.org\/10.3390\/ijms23031450)"},{"key":"bib78","series-title":"Genes and Development","first-page":"884","article-title":"The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor","volume":"22","author":"Schlisio","year":"2008","unstructured":"Schlisio SKenchappa RSVredeveld LCGeorge REStewart RGreulich HShahriari KNguyen NVPigny PDahia PL2008The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes and Development22884\u2013893. (https:\/\/doi.org\/10.1101\/gad.1648608)"},{"key":"bib79","series-title":"American Journal of Human Genetics","first-page":"84","article-title":"Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents","volume":"66","author":"Sgambati","year":"2000","unstructured":"Sgambati MTStolle CChoyke PLWalther MMZbar BLinehan WMGlenn GM2000Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. American Journal of Human Genetics6684\u201391. (https:\/\/doi.org\/10.1086\/302726)"},{"key":"bib80","series-title":"Clinical Cancer Research","first-page":"2301","article-title":"Recurrent mutations of chromatin remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","author":"Toledo","year":"2016","unstructured":"Toledo RAQin YCheng ZMGao QIwata SSilva GMPrasad MLOcal ITRao SAronin N2016Recurrent mutations of chromatin remodeling genes and kinase receptors in pheochromocytomas and paragangliomas. Clinical Cancer Research222301\u20132310. (https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1841)"},{"key":"bib81","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"438","article-title":"Clinical aspects of SDHA-related pheochromocytoma and paraganglioma: a nationwide study","volume":"103","author":"van der Tuin","year":"2018","unstructured":"van der Tuin KMensenkamp ARTops CMJCorssmit EPMDinjens WNvan de Horst-Schrivers ANAJansen JCde Jong MMKunst HPMKusters B2018Clinical aspects of SDHA-related pheochromocytoma and paraganglioma: a nationwide study. Journal of Clinical Endocrinology and Metabolism103438\u2013445. (https:\/\/doi.org\/10.1210\/jc.2017-01762)"},{"key":"bib82","series-title":"New England Journal of Medicine","first-page":"306","article-title":"Somatic SDHB mutation in an extraadrenal pheochromocytoma","volume":"357","author":"van Nederveen","year":"2007","unstructured":"van Nederveen FHKorpershoek ELenders JWde Krijger RRDinjens WN2007Somatic SDHB mutation in an extraadrenal pheochromocytoma. New England Journal of Medicine357306\u2013308. (https:\/\/doi.org\/10.1056\/NEJMc070010)"},{"key":"bib83","series-title":"Journal of Pathology","first-page":"378","article-title":"Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas","volume":"251","author":"Wallace","year":"2020","unstructured":"Wallace PWConrad CBruckmann SPang YCaleiras EMurakami MKorpershoek EZhuang ZRapizzi EKroiss M2020Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas. Journal of Pathology251378\u2013387. (https:\/\/doi.org\/10.1002\/path.5472)"},{"key":"bib84","series-title":"World Journal of Surgery","first-page":"482","article-title":"Activating FGFR1 mutations in sporadic pheochromocytomas","volume":"42","author":"Welander","year":"2018","unstructured":"Welander JLysiak MBrauckhoff MBrunaud LSoderkvist PGimm O2018Activating FGFR1 mutations in sporadic pheochromocytomas. World Journal of Surgery42482\u2013489. (https:\/\/doi.org\/10.1007\/s00268-017-4320-0)"},{"key":"bib85","series-title":"Hormone and Metabolic Research","first-page":"419","article-title":"The 3PAs: an update on the association of pheochromocytomas, paragangliomas, and pituitary tumors","volume":"51","author":"Xekouki","year":"2019","unstructured":"Xekouki PBrennand AWhitelaw BPacak KStratakis CA2019The 3PAs: an update on the association of pheochromocytomas, paragangliomas, and pituitary tumors. Hormone and Metabolic Research51419\u2013436. (https:\/\/doi.org\/10.1055\/a-0661-0341)"},{"key":"bib86","series-title":"Genes and Development","first-page":"1326","article-title":"Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","unstructured":"Xiao MYang HXu WMa SLin HZhu HLiu LLiu YYang CXu Y2012Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes and Development261326\u20131338. (https:\/\/doi.org\/10.1101\/gad.191056.112)"},{"key":"bib87","series-title":"New England Journal of Medicine","first-page":"922","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","unstructured":"Zhuang ZYang CLorenzo FMerino MFojo TKebebew EPopovic VStratakis CAPrchal JTPacak K2012Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. New England Journal of Medicine367922\u2013930. (https:\/\/doi.org\/10.1056\/NEJMoa1205119)"}],"container-title":["Journal of Molecular Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/jme.bioscientifica.com\/view\/journals\/jme\/70\/3\/JME-22-0167.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jme.bioscientifica.com\/downloadpdf\/journals\/jme\/70\/3\/JME-22-0167.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jme.bioscientifica.com\/downloadpdf\/journals\/jme\/70\/3\/JME-22-0167.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:54:17Z","timestamp":1784555657000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/jme\/article\/14541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":87,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/jme-22-0167","relation":{},"ISSN":["0952-5041","1479-6813"],"issn-type":[{"value":"0952-5041","type":"print"},{"value":"1479-6813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}